Markus Hansson
51 – 60 of 72
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
A phase 1 dose-escalation study of antibody BI-505 in relapsed/refractory multiple myeloma.
(
- Contribution to journal › Article
-
Mark
Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma.
(
- Contribution to journal › Article
-
Mark
Genetic and epigenetic characterization of hypodiploid acute lymphoblastic leukemia.
(
- Contribution to journal › Article
- 2014
-
Mark
Low production of reactive oxygen species in granulocytes is associated with organ damage in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma.
(
- Contribution to journal › Scientific review
-
Mark
Robust isolation of malignant plasma cells in multiple myeloma.
(
- Contribution to journal › Article
- 2013
-
Mark
A human icam-1 antibody isolated by a function-first approach has potent macrophage-dependent antimyeloma activity in vivo.
(
- Contribution to journal › Article
- 2012
-
Mark
Remission maintenance in acute myeloid leukemia: impact of functional histamine H-2 receptors expressed by leukemic cells
(
- Contribution to journal › Article
-
Mark
Monocytic AML cells inactivate antileukemic lymphocytes: role of NADPH oxidase/gp91(phox) expression and the PARP-1/PAR pathway of apoptosis
(
- Contribution to journal › Article
- 2010
-
Mark
Neutrophil elastase and proteinase 3 trafficking routes in myelomonocytic cells.
(
- Contribution to journal › Article